BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8294313)

  • 1. Coagulation disorders in patients with monoclonal gammopathies.
    Keren DF
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1153-9. PubMed ID: 8294313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Index of light kappa/lambda and lambda/kappa chains in monoclonal gammopathies.
    Tichý M; Hrncír Z
    Neoplasma; 1990; 37(1):55-9. PubMed ID: 2108394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy to diagnose monoclonal gammopathies in serum: high-resolution electrophoresis, immunofixation, and kappa/lambda quantification.
    Keren DF; Warren JS; Lowe JB
    Clin Chem; 1988 Nov; 34(11):2196-201. PubMed ID: 3141081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal gammopathies in a series of 1683 plasma donors].
    Tichý M; Rehácek V; Maisnar V; Dominiková K; Palicka V
    Cas Lek Cesk; 2004; 143(6):401-4; discussion 404. PubMed ID: 15309868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
    Wood PB; McElroy YG; Stone MJ
    Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F; Thiry C; Willems D
    Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
    Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
    Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences in the diagnosis and treatment of polyneuropathies in patients with malignant monoclonal gammopathy].
    Baumann I; Krause T; Schwenke H; Lehmann J
    Psychiatr Neurol Med Psychol (Leipz); 1990 Feb; 42(2):85-95. PubMed ID: 2158116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies:  High False-Positive Rate.
    Singh G
    Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy in a tertiary referral hospital.
    Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
    Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM-kappa-lambda biclonal gammopathy elucidated by immunofixation electrophoresis.
    Gerard SK; Chen KH; Khayam-Bashi H
    Diagn Immunol; 1986; 4(3):155-8. PubMed ID: 3089672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biclonal gammopathies: clinical and theoretical aspects].
    Cohen Y; Ben-Bassat I
    Harefuah; 1993 Apr; 124(7):393-5, 456. PubMed ID: 8330781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
    Diamantidis MD; Ioannidou-Papagiannaki E; Ntaios G
    Clin Biochem; 2009 Jul; 42(10-11):1202-3. PubMed ID: 19375413
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy in general practice. Diagnostic value of typing and quantitation of immunoglobulins.
    Schmidt EB; Møller-Petersen J
    Scand J Prim Health Care; 1985 May; 3(2):91-4. PubMed ID: 3933073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of kappa/lambda and lambda/kappa ratio in paraproteinemias.
    Tichý M; Hrncír Z
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):313-8. PubMed ID: 6820852
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
    Smith J; Raines G; Schneider HG
    Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.